1. Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database. (1st November 2020) Authors: Foster, Shonda A.; Chen, Chi-Chang; Ding, Yao; Mason, Oksana; McGuiness, Catherine B.; Morrow, Paula; Ye, Wenyu; Wade, Rolin L.; Smith, Timothy R.; Joshi, Shivang Journal: Journal of medical economics Issue: Volume 23:Number 11(2020) Page Start: 1356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia. (2nd November 2019) Authors: Song, Xue; El Khoury, Antoine C.; Brouillette, Matthew; Smith, David; Joshi, Kruti Journal: Journal of medical economics Issue: Volume 22:Number 11(2019) Page Start: 1105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗